Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,421 | 97,027 | 48,519 | 61,067 | 58,568 |
| Marketable Securities | 12,833 | 13,404 | 10,011 | 12,008 | 21,229 |
| Receivables | 22,071 | 16,055 | 9,866 | 7,453 | 7,881 |
| TOTAL | $121,229 | $133,660 | $72,374 | $85,355 | $91,929 |
| Non-Current Assets | |||||
| PPE Net | 18,286 | 18,619 | 17,338 | 15,433 | 12,248 |
| Investments And Advances | 37,301 | 38,680 | 45,131 | 51,168 | 45,860 |
| Other Non-Current Assets | 6,101 | 6,151 | 5,259 | 5,434 | 3,633 |
| TOTAL | $61,688 | $63,450 | $67,728 | $72,035 | $61,741 |
| Total Assets | $182,917 | $197,110 | $140,102 | $157,390 | $153,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,653 | 11,609 | 5,862 | 9,462 | 5,307 |
| Accrued Expenses | 4,342 | 4,137 | 3,250 | 3,591 | 3,080 |
| Other current liabilities | N/A | N/A | N/A | 1,038 | N/A |
| TOTAL | $12,919 | $21,669 | $16,085 | $28,521 | $18,932 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,924 | 5,923 | 6,973 | 14,430 | 10,545 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,919 | $21,669 | $16,085 | $28,521 | $18,932 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,039 | 54,023 | 47,805 | N/A | 47,565 |
| Common Shares | 270 | 270 | 238 | 238 | 238 |
| Retained earnings | -91,570 | -86,037 | -79,142 | -73,826 | -66,978 |
| Other shareholders' equity | 707 | 631 | 560 | 308 | -160 |
| TOTAL | $169,998 | $175,441 | $124,017 | $128,869 | $134,738 |
| Total Liabilities And Equity | $182,917 | $197,110 | $140,102 | $157,390 | $153,670 |